TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Diagnostics Development Sweden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
606
|
454
|
225 |
| Financial expenses |
16
|
59
|
1 |
| Earnings before taxes |
255
|
14
|
-52 |
| EBITDA |
244
|
56
|
-131 |
| Total assets |
850
|
643
|
563 |
| Current assets |
541
|
300
|
165 |
| Current liabilities |
184
|
195
|
79 |
| Equity capital |
596
|
448
|
484 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
6
|
4
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
70.1%
|
69.7%
|
86.0% |
| Turnover per employee |
101
|
114
|
45 |
| Profit as a percentage of turnover |
42.1%
|
3.1%
|
-23.1% |
| Return on assets (ROA) |
31.9%
|
11.4%
|
-9.1% |
| Current ratio |
294.0%
|
153.8%
|
208.9% |
| Return on equity (ROE) |
42.8%
|
3.1%
|
-10.7% |
| Change turnover |
167
|
229
|
-357 |
| Change turnover % |
38%
|
101%
|
-61% |
| Chg. No. of employees |
2
|
-1
|
-1 |
| Chg. No. of employees % |
50%
|
-20%
|
-17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.